{"transactions":[{"id":731579,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2026-06-18T22:45:04.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":22195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":22195,"derivative":{"exercise_price":19.19,"expiration_date":"2036-06-17","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":22195},"source":{"system":"sec-edgar","filing":"0001213900-26-070256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390026070256/ownership.xml","form_type":"4"}},{"id":733954,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:36:28.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":181425,"source":{"system":"sec-edgar","filing":"0001193125-26-274256","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000119312526274256/ownership.xml","form_type":"4"}},{"id":1091048,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2025-07-07T20:03:16.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":false,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested."}],"balance_after":21500,"derivative":{"exercise_price":12.25,"expiration_date":"2032-04-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001213900-25-061752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390025061752/ownership.xml","form_type":"4"}},{"id":1091047,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares, par value $0.0001 per share","published_at":"2025-07-07T20:03:16.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":23500,"price":48.79,"value":1146565.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $48.59 to $49.01. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-25-061752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390025061752/ownership.xml","form_type":"4"}},{"id":1091046,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares, par value $0.0001 per share","published_at":"2025-07-07T20:03:16.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23500,"source":{"system":"sec-edgar","filing":"0001213900-25-061752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390025061752/ownership.xml","form_type":"4"}},{"id":1113221,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:27:41.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":117944,"source":{"system":"sec-edgar","filing":"0000950170-25-085446","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017025085446/ownership.xml","form_type":"4"}},{"id":1117314,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2025-06-09T13:06:21.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6682,"derivative":{"exercise_price":48.83,"expiration_date":"2035-06-05","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":6682},"source":{"system":"sec-edgar","filing":"0001213900-25-052366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390025052366/ownership.xml","form_type":"4"}},{"id":1471949,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:08.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":72944,"source":{"system":"sec-edgar","filing":"0000950170-24-076220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024076220/ownership.xml","form_type":"4"}},{"id":1484783,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-10T20:58:50.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":35574,"price":6.61,"value":235144.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.56 to $6.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":48633,"source":{"system":"sec-edgar","filing":"0000950170-24-071393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024071393/ownership.xml","form_type":"4"}},{"id":1484782,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-10T20:58:50.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":44426,"price":6.36,"value":282549.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":84207,"source":{"system":"sec-edgar","filing":"0000950170-24-071393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000095017024071393/ownership.xml","form_type":"4"}},{"id":1486025,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2024-06-07T21:01:07.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,688 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 6, 2025, (ii) the date of the Issuer's next annual general meeting of shareholders and (iii) the date of a Change in Control (as defined in the MoonLake Immunotherapeutics 2022 Equity Incentive Plan) of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":7688,"derivative":{"exercise_price":42.44,"expiration_date":"2034-06-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001213900-24-050835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390024050835/ownership.xml","form_type":"4"}},{"id":1704728,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-19T21:05:17.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":1572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023."}],"balance_after":128633,"source":{"system":"sec-edgar","filing":"0001209191-23-059113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123059113/doc4.xml","form_type":"4"}},{"id":1777229,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-19T21:05:03.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":2098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023."}],"balance_after":127061,"source":{"system":"sec-edgar","filing":"0001209191-23-049998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123049998/doc4.xml","form_type":"4"}},{"id":1846428,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-22T21:30:51.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":22350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":124963,"source":{"system":"sec-edgar","filing":"0001209191-23-039142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123039142/doc4.xml","form_type":"4"}},{"id":1849413,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-20T20:05:35.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023."}],"balance_after":102613,"source":{"system":"sec-edgar","filing":"0001209191-23-038340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123038340/doc4.xml","form_type":"4"}},{"id":1858204,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2023-06-12T20:49:14.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":11297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":11297,"derivative":{"exercise_price":29.18,"expiration_date":"2033-06-08","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":11297},"source":{"system":"sec-edgar","filing":"0001213900-23-048197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390023048197/ownership.xml","form_type":"4"}},{"id":1946768,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-17T20:05:12.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":1677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023."}],"balance_after":101027,"source":{"system":"sec-edgar","filing":"0001209191-23-019597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919123019597/doc4.xml","form_type":"4"}},{"id":2244468,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-03T20:05:53.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":21571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":99350,"source":{"system":"sec-edgar","filing":"0001209191-22-033969","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919122033969/doc4.xml","form_type":"4"}},{"id":2280459,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2022-05-05T21:47:33.000Z","date":"2022-04-06","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Ms. Moukheibir was granted 45,000 options on April 6, 2022 pursuant to the MoonLake Immunotherapeutics 2022 Equity Incentive Plan (the \"Plan\"), vesting one-third on each of April 6, 2023, April 6, 2024 and April 6, 2025, in each case, subject to the terms of the Plan. Each option represents the right to acquire one Class A ordinary share, par value $0.0001 per share, of the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":12.25,"expiration_date":"2032-04-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001213900-22-024303","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1772130/000121390022024303/ownership.xml","form_type":"4"}},{"id":2327162,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-17T20:05:26.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":1466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":77779,"source":{"system":"sec-edgar","filing":"0001209191-22-019522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919122019522/doc4.xml","form_type":"4"}},{"id":2465866,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-17T21:04:17.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":1541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":76313,"source":{"system":"sec-edgar","filing":"0001209191-21-070230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121070230/doc4.xml","form_type":"4"}},{"id":2565618,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-09-17T20:47:50.000Z","date":"2021-09-15","kind":"grant","acquired":true,"shares":1447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":74772,"source":{"system":"sec-edgar","filing":"0001209191-21-056657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121056657/doc4.xml","form_type":"4"}},{"id":2666175,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-16T20:33:16.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":1565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":73325,"source":{"system":"sec-edgar","filing":"0001209191-21-040924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121040924/doc4.xml","form_type":"4"}},{"id":2680852,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-04T20:15:13.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":22766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":71760,"source":{"system":"sec-edgar","filing":"0001209191-21-038205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121038205/doc4.xml","form_type":"4"}},{"id":2782012,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-03-17T20:01:22.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":1573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Policy, effective May 2019."}],"balance_after":48994,"source":{"system":"sec-edgar","filing":"0001209191-21-021296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919121021296/doc4.xml","form_type":"4"}},{"id":3120231,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-05T20:36:18.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":21720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":47421,"source":{"system":"sec-edgar","filing":"0001209191-20-034697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919120034697/doc4.xml","form_type":"4"}},{"id":3506293,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-31T20:13:49.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":22706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":25701,"source":{"system":"sec-edgar","filing":"0001209191-19-033633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119033633/doc4.xml","form_type":"4"}},{"id":3564603,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":36673,"kind":"person","name":"Moukheibir Catherine","position":1,"cik":"0001772130","reported_name":"Moukheibir Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-04-03T22:46:40.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":2995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":2995,"source":{"system":"sec-edgar","filing":"0001209191-19-023463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1446847/000120919119023463/doc4.xml","form_type":"4"}}]}